share_log

Marker Therapeutics Q3 EPS $(0.34) Up From $(0.80) YoY, Sales $257.61K Down From $3.95M YoY

Benzinga ·  Nov 9, 2023 19:03

Marker Therapeutics (NASDAQ:MRKR) reported quarterly losses of $(0.34) per share. This is a 57.5 percent increase over losses of $(0.80) per share from the same period last year. The company reported $257.61 thousand in sales this quarter. This is a 93.48 percent decrease over sales of $3.95 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment